OPKO Health (OPK) said Friday its board has authorized a $100 million increase to its share buyback program, bringing it to a total of $200 million.
About $41 million of stock has already been repurchased under the existing program, the biopharmaceutical company said.
OPKO Health said it expects to fund the repurchase program from existing cash, cash equivalents, and future cash flows.